ASK REDCHAT ANYTHING ABOUT HUMACYTE INC.
Humacyte Inc. (NASDAQ: HUMA)
Listen to this Section
$1.37
-0.1250
(
-8.39% )
4.7M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Human Acellular Vessel (HAV)DetailsDialysis access (AV access) |
Phase 3 |
| Humacyte Acellular Tissue Engineered Vessel (ATEV™)DetailsDialysis access (AV access) |
Phase 3 |
Market Data
|
| Open |
$1.37 |
| Previous Close |
$1.49 |
| Volume |
4.7M |
| Market Cap |
$310.83M |
| Day Range |
$1.36 - $1.52 |
| 52 Week Range |
$0.55 - $2.93 |
| Shares Outstanding |
222.02M |
| Change % |
-8.39% |
| Net Change |
▼ -0.1250 |
| Insider Ownership |
-0.25% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-11,429,032.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-08-21 |
Sale |
-570174.00 |
Dougan Brady W |
| 2023-08-21 |
Sale |
-570174.00 |
Ayabudge LLC |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
15 |
Nov 12, 2025 |
| 10-q |
Quarterly Reports |
131 |
Nov 12, 2025 |
| 8-k |
8K-related |
22 |
Oct 07, 2025 |
| 8-k |
8K-related |
170 |
Sep 18, 2025 |
| 4 |
Insider transactions |
1 |
Aug 20, 2025 |
| 4 |
Insider transactions |
1 |
Aug 20, 2025 |
| 10-q |
Quarterly Reports |
83 |
Aug 11, 2025 |
| 8-k |
8K-related |
15 |
Aug 11, 2025 |
| 4 |
Insider transactions |
1 |
Jun 16, 2025 |
| 4 |
Insider transactions |
1 |
Jun 16, 2025 |